BRPI1015539A2 - composições e métodos para tratamento de queimaduras - Google Patents
composições e métodos para tratamento de queimadurasInfo
- Publication number
- BRPI1015539A2 BRPI1015539A2 BRPI1015539A BRPI1015539A BRPI1015539A2 BR PI1015539 A2 BRPI1015539 A2 BR PI1015539A2 BR PI1015539 A BRPI1015539 A BR PI1015539A BR PI1015539 A BRPI1015539 A BR PI1015539A BR PI1015539 A2 BRPI1015539 A2 BR PI1015539A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- treatment compositions
- burn treatment
- compositions
- treating burns
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
composições e métodos para tratamento de queimaduras a presente invenção fornece composições e métodos para tratar queimaduras que compreendem administrar a uma área de queimadura de um indivíduo que precise uma quantidade terapeuticamente eficaz de uma composição que compreende um agente anticitocina ou anti-inflamatório, ou um derivado funcional disso; e um excipiente farmaceuticamente aceitável.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/429,169 US20100266709A1 (en) | 2004-12-16 | 2009-04-23 | Compositions and Methods for Treating Burns |
PCT/US2010/031315 WO2010123759A2 (en) | 2009-04-23 | 2010-04-15 | Compositions and methods for treating burns |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1015539A2 true BRPI1015539A2 (pt) | 2019-07-09 |
Family
ID=43011691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1015539A BRPI1015539A2 (pt) | 2009-04-23 | 2010-04-15 | composições e métodos para tratamento de queimaduras |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100266709A1 (pt) |
EP (1) | EP2429535A2 (pt) |
JP (1) | JP2012524782A (pt) |
KR (1) | KR20120013404A (pt) |
CN (1) | CN102438633A (pt) |
AU (1) | AU2010239515A1 (pt) |
BR (1) | BRPI1015539A2 (pt) |
CA (1) | CA2760359A1 (pt) |
IL (1) | IL215932A0 (pt) |
MX (1) | MX2011011126A (pt) |
WO (1) | WO2010123759A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014102619A2 (en) * | 2012-12-24 | 2014-07-03 | Avi Dascalu | Compositions of aluminum fluoride and methods of use thereof for the treatment and prevention of actinic keratosis and sun-induced damages |
KR101593208B1 (ko) * | 2014-05-13 | 2016-02-12 | 주식회사 티앤엘 | 에어로졸 스프레이형 하이드로겔 화상치료제 |
WO2018031967A1 (en) * | 2016-08-12 | 2018-02-15 | L.E.A.F. Holdings Group Llc | Polyglutamated antifolates and uses thereof |
JP7227123B2 (ja) | 2016-08-12 | 2023-02-21 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | αおよびγ-Dポリグルタミン酸化抗葉酸剤およびその使用 |
KR101792535B1 (ko) | 2017-09-27 | 2017-11-02 | 오상자이엘 주식회사 | 화상 치료용 키트 |
CN111954531A (zh) | 2018-02-07 | 2020-11-17 | L.E.A.F.控股集团公司 | α聚谷氨酸化培美曲塞及其用途 |
EP3749320A4 (en) * | 2018-02-07 | 2022-03-09 | L.E.A.F Holdings Group LLC | ALPHA-POLYGLUTAMATED AMINOPTERIN AND ITS USES |
US11730738B2 (en) | 2018-02-07 | 2023-08-22 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
CA3090943A1 (en) * | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated aminopterin and uses thereof |
EP3752157A4 (en) | 2018-02-14 | 2022-07-06 | L.E.A.F Holdings Group LLC | GAMMA-POLYGLUTAMATED LOMETREXOLE AND USES THEREOF |
KR102313197B1 (ko) * | 2018-07-11 | 2021-10-18 | 강형철 | 고체상염의 삼투작용으로 수포형성을 억제하는 화상 응급처치용 치료 제제 및 이를 포함하는 패치 |
US11918570B2 (en) | 2020-04-13 | 2024-03-05 | The Research Foundation For The State University Of New York | Method of treatment for prevention of glucocorticoid toxicity and/or enhancement of muscle regeneration via neutrophil elastase inhibition |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2352895A1 (fr) * | 1976-04-21 | 1977-12-23 | Diversey France | Nouveau procede de traitement de surfaces metalliques au moyen de composes oxyfluores du phosphore 5 |
US4342857A (en) * | 1980-12-31 | 1982-08-03 | Colgate-Palmolive Company | Antigingivitis composition comprising vinyl phosphonic acid/vinyl phosphonyl fluoride copolymer |
US4490529A (en) * | 1983-09-06 | 1984-12-25 | Dana-Farber Cancer Institute, Inc. | Cysteic acid and homocysteic acid analogues of methotrexate and aminopterin |
US4828832A (en) * | 1983-09-07 | 1989-05-09 | Laboratorios Biochemie De Mexico | Method of manufacturing a composition for treating skin lesions |
US4632920A (en) * | 1984-09-27 | 1986-12-30 | University Of Medicine & Dentistry Of New Jersey | Process for treating a warm-blooded animal following burn injury |
US5641814A (en) * | 1991-03-01 | 1997-06-24 | Warner-Lambert Company | Antikeratolytic-wound healing compositions and methods for preparing and using same |
US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
US5674912A (en) * | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
US5602183A (en) * | 1991-03-01 | 1997-02-11 | Warner-Lambert Company | Dermatological wound healing compositions and methods for preparing and using same |
US5489435A (en) * | 1993-07-06 | 1996-02-06 | Ratcliff; Perry A. | Composition for treatment of abnormal conditions of the epithelium of bodily orifices |
US6060501A (en) * | 1994-06-02 | 2000-05-09 | Schering Aktiengesellschaft | Combined treatment of multiple sclerosis |
US5807541A (en) * | 1996-04-22 | 1998-09-15 | Sepracor, Inc. | NSAID/fluoride periodontal compositions and methods |
US6348185B1 (en) * | 1998-06-20 | 2002-02-19 | Washington University School Of Medicine | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US6660306B2 (en) * | 2000-10-12 | 2003-12-09 | Mickey L. Peshoff | Wound healing compound |
EP1490044A4 (en) * | 2002-03-29 | 2008-04-16 | Neurogen Corp | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMABLE COMPONENTS |
CA2405241C (en) * | 2002-09-24 | 2011-07-26 | Nova Chemicals Corporation | Olefin polymerization catalyst system |
WO2005032470A2 (en) * | 2003-09-30 | 2005-04-14 | Kohi Corporation | Compositions and methods for treating burns |
-
2009
- 2009-04-23 US US12/429,169 patent/US20100266709A1/en not_active Abandoned
-
2010
- 2010-04-15 JP JP2012507274A patent/JP2012524782A/ja not_active Withdrawn
- 2010-04-15 WO PCT/US2010/031315 patent/WO2010123759A2/en active Application Filing
- 2010-04-15 CN CN2010800178644A patent/CN102438633A/zh active Pending
- 2010-04-15 MX MX2011011126A patent/MX2011011126A/es not_active Application Discontinuation
- 2010-04-15 AU AU2010239515A patent/AU2010239515A1/en not_active Abandoned
- 2010-04-15 KR KR1020117027909A patent/KR20120013404A/ko not_active Application Discontinuation
- 2010-04-15 EP EP10767548A patent/EP2429535A2/en not_active Withdrawn
- 2010-04-15 CA CA2760359A patent/CA2760359A1/en not_active Abandoned
- 2010-04-15 BR BRPI1015539A patent/BRPI1015539A2/pt not_active IP Right Cessation
-
2011
- 2011-10-25 IL IL215932A patent/IL215932A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102438633A (zh) | 2012-05-02 |
AU2010239515A1 (en) | 2011-12-15 |
MX2011011126A (es) | 2012-04-02 |
EP2429535A2 (en) | 2012-03-21 |
JP2012524782A (ja) | 2012-10-18 |
US20100266709A1 (en) | 2010-10-21 |
CA2760359A1 (en) | 2010-10-28 |
IL215932A0 (en) | 2011-12-29 |
KR20120013404A (ko) | 2012-02-14 |
WO2010123759A2 (en) | 2010-10-28 |
WO2010123759A9 (en) | 2011-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1015539A2 (pt) | composições e métodos para tratamento de queimaduras | |
BR112015010477A2 (pt) | combinação farmacêutica que compreende um inibidor b-raf e um inibidor de histona desacetilase e o uso dos mesmos no tratamento de doenças proliferativas | |
MX366175B (es) | Composiciones fosfolipidicas terapeuticas concentradas. | |
EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
EA201491358A1 (ru) | Вводимые перорально кортикостероидные композиции | |
BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
IN2015DN00376A (pt) | ||
BRPI0809164B8 (pt) | Composição para administração tópica e composição farmacêutica compreendendo a referida composição | |
SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
BR112014031394A2 (pt) | composições e métodos para absorção transmucosa | |
BR112015011171A2 (pt) | compostos de pirrolopirimidina como inibidores da quinase | |
EA201001865A1 (ru) | Противовоспалительные агенты | |
DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
BR112015007778A2 (pt) | profármacos neutralizantes de vegf para o tratamento de condições oculares | |
GT200700034A (es) | Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40 | |
BRPI0622054B8 (pt) | composto e composição farmacêutica | |
BRPI0922789A2 (pt) | peptídeo de ligação de albumina intermediador para reconhecimento de doença | |
CR9427A (es) | Combinacion terapeutica en casos de hiperplasia prostatica benigna | |
EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
BRPI0806863B8 (pt) | uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv | |
CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
BR112017016087A2 (pt) | formulações para coxim articular adiposo e métodos de uso das mesmas | |
MX2010009624A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. | |
BRPI0518448A2 (pt) | composiÇÕes farmacÊuticas compreendendo um derivado de camptotecina | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2532 DE 16-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |